Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

American men are older, more obese, and have longer infertility than Canadian men.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Low selenium intake may delay puberty in boys but not in girls.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Video teaching greatly improved PCOS knowledge among female engineering students.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Topical tofacitinib is effective and safe for treating alopecia areata.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Skin diseases have a small to moderate impact on the quality of life of patients in Goa, India.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.